TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05412160

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Arginine
Description: During the first assessment the patients will be randomized to receive BioArginine C™ twice daily on top of chronic inhaled therapy or to continue their chronic Inhaled therapy plus placebo for 6 weeks. The main purpose is to compare changes in CRQ from baseline and after 6 weeks in the interventional arm compared with the control group in order to evaluate whether in symptomatic patients with COPD, daily bioarginine on top of chronic inhaled therapy can improve respiratory symptoms and dyspnea. The secondary objective of the study is to determine whether there is any correlation between improvement in respiratory symptoms and distance walked at the 6MWT and lung function parameters.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: During the first assessment the patients will be randomized to receive BioArginine C™ twice daily on top of chronic inhaled therapy or to continue their chronic Inhaled therapy plus placebo for 6 weeks. The main purpose is to compare changes in CRQ from baseline and after 6 weeks in the interventional arm compared with the control group in order to evaluate whether in symptomatic patients with COPD, daily bioarginine on top of chronic inhaled therapy can improve respiratory symptoms and dyspnea. The secondary objective of the study is to determine whether there is any correlation between improvement in respiratory symptoms and distance walked at the 6MWT and lung function parameters.
Study: NCT05523791

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Fortiral
Description: Twice a day, patients took 10 g of powder containing 92.5% whey protein with 2.7% cysteine; emulsifier: soy lecithin, lactose free to be reconstituted with 150-200 ml of water.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Mg++
Description: Twice a day, patients took 2.250g of magnesium pidolate (=184 mg of Magnesium++ ione) powder twice a day to be reconstituted with 150-200 ml of water
Study: NCT06463002

Intervention type: DIAGNOSTIC_TEST
Intervention: Ambulatory blood pressure monitoring and Montreal Cognitive Assessment
Description: Noninvasive tests to assess blood pressure control and cognition

Intervention type: DIAGNOSTIC_TEST
Intervention: Ambulatory blood pressure monitoring and Montreal Cognitive Assessment
Description: Noninvasive tests to assess blood pressure control and cognition

Intervention type: DIAGNOSTIC_TEST
Intervention: Ambulatory blood pressure monitoring and Montreal Cognitive Assessment
Description: Noninvasive tests to assess blood pressure control and cognition
Study: NCT05472545

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Neurofeedback
Description: Real-time functional magnetic resonance imaging dyadic neurofeedback
Study: NCT05553964

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: In Vitro
Description: In vitro diagnostic test for COVID-19 using anterior nasal swabs.
Study: NCT05104034

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Osteoporosis screening and treatment as needed
Description: All residents underwent screening using the Fracture Risk Assessment Tool (FRAX) and Mobile dual-energy X-ray absorptiometry (DXA) (Horizon Wi, Hologic Inc., Bedford, MA). Our study nurses actively assisted osteoporosis treatment if indicated.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Osteoporosis screening and treatment as needed
Description: All residents underwent screening using the Fracture Risk Assessment Tool (FRAX) and Mobile dual-energy X-ray absorptiometry (DXA) (Horizon Wi, Hologic Inc., Bedford, MA). Our study nurses actively assisted osteoporosis treatment if indicated.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Osteoporosis screening and treatment as needed
Description: All residents underwent screening using the Fracture Risk Assessment Tool (FRAX) and Mobile dual-energy X-ray absorptiometry (DXA) (Horizon Wi, Hologic Inc., Bedford, MA). Our study nurses actively assisted osteoporosis treatment if indicated.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sarcopenia
Description: Sarcopenia assessment adhered to the 2019 Consensus Update on Sarcopenia Diagnosis and Treatment by the Asian Working Group for Sarcopenia guideline. Following screening, individuals identified with sarcopenia underwent tailored interventions involving exercise and nutrition as deemed necessary.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: TheraBand (resistance band) was utilized as the exercise tool within the community. T

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Nutrition
Description: Nutrition Nutritional education programs aim to increase protein food serving and the choice of those with insufficient dietary intake. Protein supplement was added if indicated.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pharmaceutical care
Description: We collected drug information of the elderly. Detailed and real-time prescription drug information was retrieved from the National Health Insurance PharmaCloud System. A pharmaceutical care team performed patient-centered drug review and discussion every three to six months.
Study: NCT06397898

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Educational video
Description: Viewing an educational video before Novasure treatment
Study: NCT05413707

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Fixation of the posterior malleolus fractures
Description: Fixation of the posterior malleolus fracture with screws and or plating.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Fixation of lateral and/or medial malleolus fractures
Description: Fixation with screws and/or plating

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Fixation of lateral and/or medial malleolus fractures
Description: Fixation with screws and/or plating

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Syndesmotic fixation
Description: Fixation of unstable syndesmosis with one or two 3.5 mm tricortical screws, or with a suture button.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Syndesmotic fixation
Description: Fixation of unstable syndesmosis with one or two 3.5 mm tricortical screws, or with a suture button.
Study: NCT06196333

Intervention type: DEVICE
Intervention: Non-contact specular microscopy
Description: using specular microscope to do morphological examination of corneal endothelial cells

Intervention type: DEVICE
Intervention: Non-contact specular microscopy
Description: using specular microscope to do morphological examination of corneal endothelial cells
Study: NCT05976503

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tunodafil Hydrochloride Tablets
Description: 100mg Tunodafil Hydrochloride Tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tunodafil Hydrochloride Tablets
Description: 100mg Tunodafil Hydrochloride Tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo
Study: NCT06246890

Intervention type: OTHER
Intervention: Autism ALERT
Description: Autism Access Link for Early Referral and Treatment \[ALERT\], the intervention proposed in this application, is a novel state-wide referral and case management platform that PCPs can activate to ensure that a child with suspected ASD receives all necessary ASD diagnosis and treatment resources in a single referral, radically simplifying a complex diagnostic and treatment process.
Study: NCT05071677

Intervention type: PROCEDURE
Intervention: Discussion
Description: Participate in treatment planning meeting

Intervention type: OTHER
Intervention: Interview
Description: Participate in interview
Study: NCT05976503

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Alcohol
Description: 0.5 g/kg alcohol

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Alcohol
Description: 0.5 g/kg alcohol
Study: NCT05855005

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DTC Hearing Aids
Description: DTC hearing aid programmed to the individual participant.
Study: NCT06441175

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intubation device order
Description: D-V group: the group that performs direct laryngoscopy first and then videolaryngoscopy.~V-D group: the group that performs video laryngoscopy first and then directlaryngoscopy.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intubation device order
Description: D-V group: the group that performs direct laryngoscopy first and then videolaryngoscopy.~V-D group: the group that performs video laryngoscopy first and then directlaryngoscopy.
Study: NCT06213142

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CBToolkit
Description: CB Toolkit Mindful Awareness module to increase awareness and tolerance of physical sensations and emotional experiences using mindfulness practices. The module involves videos with motion graphics, video demos, voiceover, music, and sound effects intermixed throughout with a variety of interactive exercises tailored to specific core components. The module aims to establish understanding of the intervention concept (psychoeducation), increase self-efficacy in mindfulness skills via active practice and personalized feedback, and facilitate self-reflection and understanding of strengths and improvement areas related to mindfulness. CBToolkit Flexible Problem Solving module to promote cognitive flexibility, applying problem-solving strategies in difficult scenarios, and learning to modify behavioral action tendencies. Videos and activities will be tailored to provide examples of effective problem-solving techniques and provide personalized reinforcing and/or scaffolded feedback.
Study: NCT05071677

Intervention type: OTHER
Intervention: Survey Administration
Description: Complete survey
Study: NCT05280067

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ZetaFuse™ Bone Graft
Description: The ZetaFuse™ Bone Graft will be percutaneously implanted into the vertebral body defect(s) created by the lytic metastatic tumor.
Study: NCT05081011

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Voice Assistant Device
Description: Voice AI-enabled smart speaker device delivers daily custom insulin titration instructions.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Voice Assistant Device
Description: Voice AI-enabled smart speaker device delivers daily generic insulin reminders.
Study: NCT05361499

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Sp_6B
Description: Intranasal inoculation of Streptococcus pneumoniae serotype 6B, 160,000 colony forming units (CFU)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amoxicillin 500 mg
Description: Amoxicillin, 7 days, 2x 500 mg
Study: NCT05216731

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Femoro-popliteal bypass
Description: Under general or local anesthesia: Use of the best vascular substitute (inverted saphenous vein or vascular prosthesis).

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Endovascular procedure
Description: Under general anesthesia, local anesthesia or sedation: Performing a balloon angioplasty completed by preferred stent deployment or drug-coated balloon angioplasty.
Study: NCT04741009

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CI632 Slim Modiolar Electrode
Description: Cochlear Ltd CI632 cochlear implant with Slim Modiolar Electrode
Study: NCT04567459

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Premium Amino Acids
Description: after Chemotherapy ang surgery one pack of Premium Amino Acids in the morning and evening
Study: NCT05715684

Intervention type: OTHER
Group type: OTHER
Intervention: Exercise Training
Description: Virtually supervised exercise training for four weeks prior to cystectomy
Study: NCT05256420

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Kinesiotape
Description: Application of a kinesiotape bandage on the knee.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Bandage
Description: Application of a sham bandage on the knee.
Study: NCT05715684

Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Nutritional Intervention
Description: Patients scheduled to undergo cystectomy will receive liquid Ensure supplemental shakes for 2 weeks prior to surgery and liquid Ensure supplemental shakes for 1 week postoperatively
Study: NCT06317623

Intervention type: DIAGNOSTIC_TEST
Intervention: Prenatal and postnatal ultrasound examination
Description: Prenatal ultrasound examination of fetus with urinary tract dilation in second trimester and next in third trimester and when the dilation is persist, the child is managed after birth by pediatric nephrologist.
Study: NCT06135701

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: One-legged knee-extensor exercise with Doppler measurements
Description: Doppler ultrasound is used while participants exercise according to the one-legged knee-extensor exercise model

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: One-legged knee-extensor exercise with Doppler measurements
Description: Doppler ultrasound is used while participants exercise according to the one-legged knee-extensor exercise model
Study: NCT05820308

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Companion Dog Walking
Description: Participants will be asked to walk their dog three times per week, for a minimum of 30 minutes each day of walking, over an 8-week period.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Attention Control Group
Description: Participants will be asked to read educational materials on dog health once per week, over an 8-week period.
Study: NCT06476457

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: STAIR Coach
Description: STAIR is a brief, low-intensity intervention targeting difficulties in affective and interpersonal regulation that tend to be a significant problem for those exposed to traumatic events.
Study: NCT05867472

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Isoflurane Inhalant Product
Description: Isoflurane will be administered using an inhalation device

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sevoflurane inhalant product
Description: Sevoflurane will be administered using an inhalation device
Study: NCT05238012

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Xuezhikang Capsule
Description: Xuezhikang Capsule, 1200mg / day, twice a day, 2 capsules each time, after meals in the morning and evening.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Atorvastatin Calcium Tablets
Description: Atorvastatin Calcium Tablets, 20mg/day, once a day, one tablet each time, before bedtime;
Study: NCT05331287

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Head position
Description: Influence of different head position on nasal endotracheal intubation

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Head position
Description: Influence of different head position on nasal endotracheal intubation

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Head position
Description: Influence of different head position on nasal endotracheal intubation
Study: NCT06300242

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Reminders
Description: Reminders

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Reminders
Description: Reminders

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Financial Incentive
Description: $50 financial incentive for getting vaccinated within 1-week

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: No special messages or incentives
Study: NCT04827329

Intervention type: OTHER
Intervention: Questionnaire
Description: Patients will complete a questionnaire regarding their anesthesia history, course and possible complications, and Questions about their treatment for their sleep disorder.

Intervention type: OTHER
Intervention: Questionnaire
Description: Patients will complete a questionnaire regarding their anesthesia history, course and possible complications, and Questions about their treatment for their sleep disorder.
Study: NCT05670548

Intervention type: OTHER
Intervention: Questionnaire survey and specimen collection
Description: A questionnaire survey was conducted when pregnant women were enrolled, and blood were collected at 24-28 gestational weeks. Placenta and umbilical cord blood are collected during delivery.

Intervention type: OTHER
Intervention: Questionnaire survey and specimen collection
Description: A questionnaire survey was conducted when pregnant women were enrolled, and blood were collected at 24-28 gestational weeks. Placenta and umbilical cord blood are collected during delivery.
Study: NCT06154941

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Giomer Varnish
Description: A light-cured Giomer varnish for prolonged hypersensitivity relief. Seals and protects exposed dentinal tubules to prevent pain. Ideal for patients experiencing loss of enamel, gingival recession

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: CPP-ACP varnish
Description: CPP binds to oral surfaces such as teeth, dentin, oral mucosa and biofilm. CPP-ACP Varnish delivers bioavailable calcium and phosphate ions to occlude dentinal tubules treating dentin hypersensitivity
Study: NCT05790499

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atorvastatin
Description: Patients are treated with atorvastatin for 2 weeks (40 mg/day), atorvastatin free for 2 weeks, atorvastatin treatment for 2 weeks, atorvastatin free for 2 weeks, a 4-week washout period (no treatment), and atorvastatin treatment for the last 4 weeks.
Study: NCT04995133

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Colistin
Description: intravenous administration
Study: NCT06061653

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: IPT plus HD-tDCS
Description: psychotherapy plus device

Intervention type: COMBINATION_PRODUCT
Group type: SHAM_COMPARATOR
Intervention: IPT plus sham HD-tDCS
Description: psychotherapy plus sham device
Study: NCT05281094

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HIL-214
Description: 2 injections - given on Day 1 and the second given between Day 29 - Day 57

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 2 injections - given on Day 1 and the second given between Day 29 - Day 57
Study: NCT06543173

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Prophylactic Catheter-based VT Ablation
Description: Prophylactic Catheter-based VT Ablation refers to a treatment strategy where participants undergo a procedure known as catheter-based ventricular tachycardia (VT) ablation shortly after receiving their primary implantable cardioverter defibrillator (ICD).
Study: NCT05037487

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Cannabis
Description: Smoked placebo cannabis

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 20 mg CBD Cannabis
Description: Smoked cannabis with CBD

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 20 mg CBD + 20 mg THC Cannabis
Description: Smoked cannabis with CBD and THC

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 20 mg THC Cannabis
Description: Smoked cannabis with THC
Study: NCT06434584

Intervention type: OTHER
Intervention: without AI assistance
Description: provide insulin dosage and confidence score without AI assistance

Intervention type: OTHER
Intervention: without AI assistance
Description: provide insulin dosage and confidence score without AI assistance
Study: NCT05562180

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Customized meal plan and grocery delivery
Description: Participants will use an app to customize their meal plans
Study: NCT05081063

Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Routine labs
Description: Routine labs will be performed with CBC, BMP, Fox screen, ROTEM viscoelastic test, PT/INR, PTT and venous lactate for standard of care for all patients.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Routine labs
Description: Routine labs will be performed with CBC, BMP, Fox screen, ROTEM viscoelastic test, PT/INR, PTT and venous lactate for standard of care for all patients.
Study: NCT05018806

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Pharmaceutical form: Tablet Route of administration: Oral

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Pharmaceutical form: Tablet Route of administration: Oral

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rilzabrutinib
Description: Pharmaceutical form: Tablet Route of administration: Oral

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rilzabrutinib
Description: Pharmaceutical form: Tablet Route of administration: Oral
Study: NCT05170750

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Foams
Description: Every subject will perform 24 randomized trials on force platform.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Foam / Orthopedic insole
Description: 3/5 of the initial population will perform static and locomotion task, with randomized conditions.
Study: NCT05507632

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Donafenib plus Sintilimab in combination with transarterial chemoembolisation
Description: Donafenib plus Sintilimab in combination with transarterial chemoembolisation (TACE)
Study: NCT06185842

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: breathing exercise, walking exercise and vaccination counseling
Description: Participants will perform diaphragmatic breathing exercises and pursed lip breathing exercises two days a week for eight weeks.~Participants will be asked to walk for 20-30 minutes every day for eight weeks. Monitoring will be done weekly.~Participants will be counseled about infectious diseases, modes of transmission and the importance of vaccination, and will be advised to receive influenza and pneumococcal vaccines recommended for this age group.~The 5A model guide will be used regarding behavioral change towards physical activity and vaccination.
Study: NCT02709031

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cicletanine + magnesium
Description: Cicletanine is an orally-dosed furopyridine drug launched or hypertension in France in 1988 (and soon thereafter in Germany by IPSEN. While the drug's maximum tolerated dose is not known, the principal concern (and so far only material concern) at higher doses is the decrease in levels of sodium and potassium. Trials so far have take n the drug up to 400 mg QD (once daily); it was well tolerated at that dose. The drug has had an excellent safety profile in its \~1.8 million patient-years of post-launch experience,~Magnesium is being added to cicletanine in order to decrease losses of potassium and sodium, thereby enhancing cicletanine's safety at higher doses.